Medication info

Normal Saline Kit Injection

Prescription medicationInjectionsIntravenous injection
Ingredient · strength
Sodium Chloride›0.9g / 100mL
Manufacturer / importer
UK Chemipharm Co., Ltd.
Appearance
A kit injection composed of a powder injection part and a colorless transparent polypropylene container holding a diluent.
Packaging
Kit - 80 milliliters/kit[x10], Kit - 100 milliliters/kit[x10], Kit - 110 milliliters/kit[x10], Kit - 250 milliliters/kit[x10]
Approval status
Active

MFDS item code 200503697 · Notified 2005.01.28 · Insurance code 672900081

Summary

Main use
Dissolution and dilution of injectable drugs; correction of water and electrolyte deficiencies
Who receives it
Adults
Adult administration
Usually, 20~1,000mL as sodium chloride is administered subcutaneously, intravenously, by intravenous infusion, or rectally. The dose and rate of administration should be adjusted appropriately according to age, body weight, and symptoms. Use an appropriate amount to dissolve and dilute injectable products.

Ingredients

Manufacturer
UK Chemipharm Co., Ltd.

Efficacy & effects

Dissolution and dilution of injectable drugs; correction of water and electrolyte deficiencies

  • Water deficiency
  • electrolyte deficiency
  • sodium deficiency
  • chloride deficiency
View approved original text

This medication is used to replenish the deficient components when there is a lack of water and electrolytes, especially sodium and chloride. It is also used for dissolving or diluting injectables. It helps to maintain the balance of body water and electrolytes and aids in the smooth administration of injectables.

How it is given

Adult administration

Usually, 20~1,000mL as sodium chloride is administered subcutaneously, intravenously, by intravenous infusion, or rectally. The dose and rate of administration should be adjusted appropriately according to age, body weight, and symptoms. Use an appropriate amount to dissolve and dilute injectable products.

Precautions

This medication may have glass particles mixed in when using ampoule injectables, so care must be taken when cutting the container. Extra caution is required when administering to children or the elderly. This medication should not be used in patients with hypernatremia, fluid overload, or those with cirrhosis accompanied by edema or ascites. Patients with heart or circulatory problems, kidney disorders, hypoproteinemia, hyponatremia, hypokalemia, and hyperchloremia should use it cautiously. Additionally, patients with peripheral or pulmonary edema, preeclampsia, hyperaldosteronism, and those undergoing corticosteroid treatment, as well as children and the elderly, also require attention. Administering this medication in large volumes or rapidly can lead to adverse effects such as congestive heart failure, edema, acidosis, and serum electrolyte imbalances. There may also be adverse reactions such as infection or pain at the injection site, phlebitis, thrombosis, extravasation, and fluid overload, so if these symptoms occur, administration should be stopped immediately and appropriate care sought. During treatment, regular clinical evaluations and laboratory tests are necessary to check the patient's fluid balance, electrolyte concentrations, and acid-base balance changes. Elderly patients require special attention as their body functions may be impaired, so the infusion rate should be slowed and dosages reduced accordingly. This medication is administered intravenously, and in preparation, normal saline solution should be used as the diluent, with 50 mL or 100 mL being optimal. During the dissolution process, the sterilization label should be removed, and the plastic bottle should be connected to the vial to add the diluent, shaking until fully dissolved, then connecting it to the infusion set. Before administration, check for color change or the presence of precipitate or crystallization in the solution, and disinfect the patient's skin and the equipment to prevent infection. In cold weather, warm it to body temperature prior to use, and after opening, it should be used immediately, with any remaining medication discarded. When replenishing water or electrolyte deficiency, the capsule part should be removed and injected slowly, and the dissolved and diluted injectable should be administered according to the prescribed dosage and frequency.

Side effects

  • Congestive heart failure
  • edema
  • acidosis
  • serum electrolyte abnormalities
  • fever
  • infection at the injection site
  • local pain
  • local reactions
  • venous irritation
  • venous thrombosis
Show 3 more
  • phlebitis
  • extravasation
  • hypervolemia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to prevent air or moisture from entering. It is important to maintain the storage temperature between 1 degree and 30 degrees Celsius at room temperature. This will help preserve the effectiveness of the medication for a longer duration.

Appearance and packaging

Appearance

A kit injection composed of a powder injection part and a colorless transparent polypropylene container holding a diluent.

Package unit

Kit - 80 milliliters/kit[x10], Kit - 100 milliliters/kit[x10], Kit - 110 milliliters/kit[x10], Kit - 250 milliliters/kit[x10]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.